|
| | Publication Year | Title | Author(s) |
| 341 | 2018 | Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma. | Metaxas, Yannis; Rivalland, Gareth; Klingbiel, Dirk; Kao, Steven; Schmid, Sabine; Nowak, Anna K; Gautschi, Oliver; Bartnick, Tammo; Hughes, Brett G; Bouchaab, Hasna; Rothschild, Sacha; Pavlakis, Nick; Wolleb, Sybille; Petrausch, Ulf; O'Byrne, Kenneth; Froesch, Patrizia; Löffler-Baumann, Melanie; Pratsch-Peter, Susanne; Russell, Prudence; Mingrone, Walter; Savic, Spasenija; Thapa, Bibhusal ; Früh, Martin; Pless, Miklos; von Moos, Roger; Mauti, Laetitia; John, Thomas |
| 342 | 19-Jan-2018 | Personalized chemosensitivity assays for mesothelioma- is it worth the effort? | John, Thomas ; Chia, Puey Ling |
| 343 | 1-Apr-2018 | Personalized Chemosensitivity Assays for Mesothelioma: Are They Worth the Effort? | John, Thomas ; Chia, Puey Ling |
| 344 | 2021 | Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials Group. | Dunn, Catherine; Hong, Wei; Gibbs, Peter; Ackland, Stephen; Sjoquist, Katrin; Tebbutt, Niall C ; Price, Timothy; Burge, Matthew |
| 345 | 1-Jun-2018 | Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. | Sjoquist, Katrin M; Renfro, Lindsay A; Simes, R John; Tebbutt, Niall C ; Clarke, Stephen; Seymour, Matthew T; Adams, Richard A; Maughan, Timothy S; Saltz, Leonard; Goldberg, Richard M; Schmoll, Hans-Joachim; Van Cutsem, Eric; Douillard, Jean-Yves; Hoff, Paulo M; Hecht, Joel Randolph; Tournigand, Christophe; Punt, Cornelis J A; Koopman, Miriam; Hurwitz, Herbert; Heinemann, Volker; Falcone, Alfredo; Porschen, Rainer; Fuchs, Charles; Diaz-Rubio, Eduardo; Aranda, Enrique; Bokemeyer, Carsten; Souglakos, Ioannis; Kabbinavar, Fairooz F; Chibaudel, Benoist; Meyers, Jeffrey P; Sargent, Daniel J; de Gramont, Aimery; Zalcberg, John R |
| 346 | Sep-2022 | Perspectives on rectal cancer surgical prehabilitation: time to consider the pelvic floor? | Mohan, Helen; Das, Atan; Smart, Philip ; Proud, David ; Burgess, Adele N |
| 347 | 9-Jun-2012 | Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignancies. | Scott, Andrew M ; Mitchell, Paul L R ; O'Keefe, Graeme J; Saunder, Timothy; Hicks, Rodney J; Poon, Aurora M T ; Baum, Charles; Brega, Nicoletta; McCarthy, Timothy J; Toner, Guy C |
| 348 | 1-Jun-2021 | A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806. | Gan, Hui K ; Burge, Matthew; Solomon, Benjamin; Lee, Sze Ting ; Holen, Kyle D; Zhang, Yumin; Ciprotti, Marika; Lee, F T; Manusinghe, Wijth; Fischer, Judee; Ansell, Peter; Fox, Gerard; Xiong, Hao; Reilly, Edward B; Humerickhouse, Rod; Scott, Andrew M |
| 349 | 19-Nov-2005 | A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors. | Gan, Hui K ; Mitchell, Paul L R ; Galettis, Peter; Davis, Ian D; Cebon, Jonathan S ; de Souza, Paul; Links, Matthew |
| 350 | Aug-2022 | A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers. | Gan, Hui K ; Parakh, Sagun ; Lee, Fook-Thean; Tebbutt, Niall C ; Ameratunga, Malaka; Lee, Sze Ting ; O'Keefe, Graeme J; Gong, Sylvia J; Vanrenen, Christine; Caine, Jaren; Giovannetti, Mara; Murone, Carmel ; Scott, Fiona E; Guo, Nancy; Burvenich, Ingrid J G; Paine, Cameron; Macri, Mary J; Kotsuma, Masakatsu; Senaldi, Giorgio; Venhaus, Ralph; Scott, Andrew M |
| 351 | 2022 | Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours. | Lickliter, Jason D; Voskoboynik, Mark; Mileshkin, Linda; Gan, Hui K ; Kichenadasse, Ganessan; Zhang, Kathy; Zhang, Maggie; Tang, Zhiyu; Millward, Michael |
| 352 | 21-Nov-2023 | A phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab in patients with advanced solid tumors. | Frentzas, Sophia; Gan, Hui K ; Cosman, Rasha; Coward, Jermaine; Tran, Ben; Millward, Michael; Zhou, Yiting; Wang, Wenjing; Xia, Dennis; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Desai, Jayesh |
| 353 | 18-Jun-2014 | A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer. | Mitchell, Paul L R ; Quinn, Michael A; Grant, Peter; Allen, David G; Jobling, Thomas W; White, Shane C; Zhao, Anne; Karanikas, Vaios; Vaughan, Hilary A; Pietersz, Geoffrey A; McKenzie, Ian F C; Gargosky, Sharron E; Loveland, Bruce E |
| 354 | 13-Oct-2009 | Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. | Herbertson, Rebecca A; Tebbutt, Niall C ; Lee, Fook-Thean; MacFarlane, David J; Chappell, Bridget; Micallef, Noel; Lee, Sze-Ting; Saunder, Timothy; Hopkins, Wendie; Smyth, Fiona E; Wyld, David K; Bellen, John; Sonnichsen, Daryl S; Brechbiel, Martin W; Murone, Carmel ; Scott, Andrew M |
| 355 | 1-Jun-2007 | A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen. | Scott, Andrew M ; Tebbutt, Niall C ; Lee, Fook-Thean; Cavicchiolo, Tina; Liu, Zhanqi; Gill, Sanjeev; Poon, Aurora M T ; Hopkins, Wendie; Smyth, Fiona E; Murone, Carmel ; MacGregor, Duncan; Papenfuss, Anthony T; Chappell, Bridget; Saunder, Timothy H; Brechbiel, Martin W; Davis, Ian D; Murphy, Roger; Chong, Geoffrey ; Hoffman, Eric W; Old, Lloyd J |
| 16 | 1-May-2003 | A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. | Scott, Andrew M ; Wiseman, Greg; Welt, Sydney; Adjei, Alex; Lee, Fook-Thean; Hopkins, Wendie; Divgi, Chaitan R; Hanson, Lorelei H; Mitchell, Paul L R ; Gansen, Denise N; Larson, Steven M; Ingle, James N; Hoffman, Eric W; Tanswell, Paul; Ritter, Gerd; Cohen, Leonard S; Bette, Peter; Arvay, Lisa; Amelsberg, Andree; Vlock, Dan; Rettig, Wolfgang J; Old, Lloyd J |
| 17 | 2023 | Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. | Carneiro, Benedito A; Papadopoulos, Kyriakos P; Strickler, John H; Lassman, Andrew B; Waqar, Saiama N; Chae, Young Kwang; Patel, Jyoti D; Shacham-Shmueli, Einat; Kelly, Karen; Khasraw, Mustafa; Bestvina, Christine M; Merrell, Ryan; Huang, Kevin; Atluri, Harisha; Ansell, Peter; Li, Rachel; Jin, Janet; Anderson, Mark G; Reilly, Edward B; Morrison-Thiele, Gladys; Patel, Kalpesh; Robinson, Randy R; Aristide, Martha R Neagu; Gan, Hui K |
| 18 | Oct-2021 | A Phase I, First-in-Human Study of GSK2849330, an Anti-HER3 Monoclonal Antibody, in HER3-Expressing Solid Tumors. | Gan, Hui K ; Millward, Michael; Jalving, Mathilde; Garrido-Laguna, Ignacio; Lickliter, Jason D; Schellens, Jan H M; Lolkema, Martijn P; Van Herpen, Carla L M; Hug, Bruce; Tang, Lihua; O'Connor-Semmes, Robin; Gagnon, Robert; Ellis, Catherine; Ganji, Gopinath; Matheny, Christopher; Drilon, Alexander |
| 19 | Jul-2020 | Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors. | Desai, Jayesh; Gan, Hui K ; Barrow, Catherine; Jameson, Michael; Atkinson, Victoria; Haydon, Andrew; Millward, Michael; Begbie, Stephen; Brown, Michael; Markman, Ben; Patterson, William; Hill, Andrew; Horvath, Lisa; Nagrial, Adnan; Richardson, Gary; Jackson, Christopher; Friedlander, Michael; Parente, Phillip; Tran, Ben; Wang, Lai; Chen, Yunxin; Tang, Zhiyu; Huang, Wendy; Wu, John; Zeng, Dewan; Luo, Lusong; Solomon, Benjamin |
| 20 | Dec-2016 | A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors | Soria, Jean-Charles; Gan, Hui K ; Blagden, SP; Plummer, R; Arkenau, HT; Ranson, M; Evans, TR; Zalcman, G; Bahleda, R; Hollebecque, A; Lemech, C; Dean, E; Brown, J; Gibson, D; Peddareddigari, V; Murray, S; Nebot, N; Mazumdar, J; Swartz, L; Auger, KR; Fleming, RA; Singh, R; Millward, M |
